Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04505839
Title First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors ST Pharm Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.